TrialInternational journal of radiation oncology, biology, physics2022

SABR for High-Risk Prostate Cancer: A Prospective Multilevel MRI-Based Dose Escalation Trial.

Raquibul Hannan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.